Perez M, Lobo F M, Yamane Y, John L, Berger C L, Edelson R L
Department of Dermatology, Yale University, New Haven, Connecticut 06510-8059.
Ann N Y Acad Sci. 1991 Dec 30;636:95-112. doi: 10.1111/j.1749-6632.1991.tb33441.x.
We previously reported producing donor-specific tolerance to alloantigens by intravenous exposure to pretreated antidonor T cells. The current study extends that work by adoptively transferring the donor-specific tolerance into naive syngeneic recipients. Eight days after BALB/c mice received histoincompatible CBA/j skin grafts, their splenocytes which included an expanded population of cells mediating rejection were treated with 100 ng/ml 8-methoxypsoralen (8-MOP) photoactivated by 1 Joule/cm2 of ultraviolet A (UVA) light prior to infusion into naive BALB/c recipients. Whereas 8-MOP itself is biologically inert, photoactivated 8-MOP crosslinks DNA by covalently binding to pyrimidine bases. Recipient BALB/c mice which had been previously demonstrated to be hyporesponsive to CBA/j alloantigens in mixed leukocyte culture (MLC), cytotoxicity (CTL) and in vivo delayed type hypersensitivity (DTH) assays were the donors of spleen cells for the adoptive transfer experiments. Fifty to one hundred million viable spleen cells from these pretreated BALB/c mice were transferred into naive syngeneic recipients which then were tested for DTH response and allograft survival to the relevant and irrelevant antigens. The radiosensitivity of this transferrable suppression was evaluated by exposing the adoptively transferred cell population to 3200 rads of C-irradiation prior to cell transfer. The phenotype of the cells transferring this suppressive response was performed by depleting specific populations of cells with monoclonal antibodies prior to cell transfer. In vivo the DTH response of the pretreated BALB/c mice was specifically suppressed to the relevant alloantigen, correlating with retention of CBA/j skin grafts for up to 42 days post engraftment without visual evidence of rejection, in comparison to control mice complete rejection of the skin graft in less than 8 days. In vitro, splenocytes from BALB/c recipients of pretreated syngeneic splenocytes containing large numbers of BALB/c anti-CBA/j T cells proliferated less in MLC and generated lower cytotoxic T cell responses to CBA/j alloantigens than did controls and suppressed the naive and sensitized BALB/c MLC and CTL responses to CBA/j alloantigen. This specific suppressive response to alloantigen was optimally transferred into syngeneic naive recipients when the adoptive transfer was performed on the sixth day after the last infusion received by the spleen cell donor mice. The adoptive transfer of this suppressive response was abrogated by the prior X-irradiation of the donor spleen cells and significantly abolished by the depletion of Thy-1+, Lyt-2+, L3T4- T lymphocytes.(ABSTRACT TRUNCATED AT 400 WORDS)
我们之前报道过,通过静脉注射预处理的抗供体T细胞可产生针对同种异体抗原的供体特异性耐受性。当前的研究通过将供体特异性耐受性过继转移至同基因的未致敏受体,对该工作进行了拓展。BALB/c小鼠接受组织不相容的CBA/j皮肤移植8天后,其脾细胞(其中包括介导排斥反应的扩增细胞群)在输注到同基因的未致敏BALB/c受体之前,先用100 ng/ml的8-甲氧基补骨脂素(8-MOP)处理,并以1焦耳/平方厘米的紫外线A(UVA)光进行光激活。虽然8-MOP本身无生物学活性,但光激活的8-MOP通过与嘧啶碱基共价结合使DNA交联。先前已证明在混合淋巴细胞培养(MLC)、细胞毒性(CTL)和体内迟发型超敏反应(DTH)试验中对CBA/j同种异体抗原反应低下的受体BALB/c小鼠,作为过继转移实验的脾细胞供体。将来自这些预处理的BALB/c小鼠的5000万至1亿个活脾细胞转移至同基因的未致敏受体,然后检测其对相关和无关抗原的DTH反应及同种异体移植存活情况。在细胞转移前,将过继转移的细胞群暴露于3200拉德的C射线照射下,以评估这种可转移抑制的放射敏感性。在细胞转移前,用单克隆抗体清除特定细胞群,以确定传递这种抑制反应的细胞表型。在体内,预处理的BALB/c小鼠的DTH反应被特异性抑制至相关同种异体抗原,这与CBA/j皮肤移植在植入后长达42天得以保留且无排斥的明显迹象相关,相比之下,对照小鼠的皮肤移植在不到8天内完全排斥。在体外,含有大量BALB/c抗CBA/j T细胞的预处理同基因脾细胞的BALB/c受体的脾细胞,在MLC中增殖较少,对CBA/j同种异体抗原产生的细胞毒性T细胞反应较低,且抑制了未致敏和致敏的BALB/c对CBA/j同种异体抗原的MLC和CTL反应。当在脾细胞供体小鼠最后一次输注后的第6天进行过继转移时,这种对同种异体抗原的特异性抑制反应能最佳地转移至同基因的未致敏受体。供体脾细胞预先进行X射线照射可消除这种抑制反应的过继转移,而清除Thy-1 +、Lyt-2 +、L3T4 - T淋巴细胞则可显著消除该反应。(摘要截短于400字)